Vincerx Pharma Inc reports results for the quarter ended in December - Earnings Summary

Vincerx Pharma

29/03/2024 21:03

* Vincerx Pharma Inc  VINC.OQ  reported a quarterly adjusted
loss
of 23 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -65 cents.  The mean expectation of
three analysts for the quarter was for a loss of 37 cents per
share. Wall Street expected results to range from -44 cents
to -24 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Vincerx Pharma Inc's reported EPS for the quarter was a
loss
of 23 cents​.
    * The company reported a quarterly loss of $4.95 million.
    * Vincerx Pharma Inc shares had risen by 413.6% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Vincerx Pharma
Inc is $9.00 
This summary was machine generated from LSEG data March 29 at
09:03 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.37          -0.23          Beat
 Sep. 30 2023      -0.46          -0.46          Met
 Jun. 30 2023      -0.60          -0.52          Beat
 Mar. 31 2023      -0.52          -0.68          Missed